Published on in Vol 7, No 3 (2018): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/8655, first published .
Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Journals

  1. Mitsumoto H, Chiuzan C, Gilmore M, Zhang Y, Simmons Z, Paganoni S, Kisanuki Y, Zinman L, Jawdat O, Sorenson E, Floeter M, Pioro E, Fernandes Filho J, Heitzman D, Fournier C, Oskarsson B, Heiman‐Patterson T, Maragakis N, Joyce N, Hayat G, Nations S, Scelsa S, Walk D, Elman L, Hupf J, McHale B. Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale. Muscle & Nerve 2020;61(2):163 View
  2. Malek E, Salameh J, Makki A. Kennedy’s disease: an under-recognized motor neuron disorder. Acta Neurologica Belgica 2020;120(6):1289 View
  3. Arnold F, Merry D. Molecular Mechanisms and Therapeutics for SBMA/Kennedy’s Disease. Neurotherapeutics 2019;16(4):928 View
  4. Querin G, Bede P, Marchand-Pauvert V, Pradat P. Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review. Frontiers in Neurology 2018;9 View
  5. Kreider R, Stout J. Creatine in Health and Disease. Nutrients 2021;13(2):447 View